0001033905-20-000119.txt : 20200806
0001033905-20-000119.hdr.sgml : 20200806
20200806130845
ACCESSION NUMBER: 0001033905-20-000119
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200804
FILED AS OF DATE: 20200806
DATE AS OF CHANGE: 20200806
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LOEWENBAUM G WALTER II
CENTRAL INDEX KEY: 0001105966
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30109
FILM NUMBER: 201080818
MAIL ADDRESS:
STREET 1: C/O 3D SYSTEMS CORPORATION
STREET 2: 333 THREE D SYSTEMS CIRCLE
CITY: ROCK HILL
STATE: SC
ZIP: 29730
FORMER NAME:
FORMER CONFORMED NAME: LOEWENBAUM G WALTER
DATE OF NAME CHANGE: 20000209
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LUMINEX CORP
CENTRAL INDEX KEY: 0001033905
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 742747608
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12212 TECHNOLOGY BLVD
STREET 2: 512-219-8020
CITY: AUSTIN
STATE: TX
ZIP: 78727
BUSINESS PHONE: 5122494741
MAIL ADDRESS:
STREET 1: 12212 TECHNOLOGY BLVD
CITY: AUSTIN
STATE: TX
ZIP: 78727
4
1
wf-form4_159673370741963.xml
FORM 4
X0306
4
2020-08-04
1
0001033905
LUMINEX CORP
LMNX
0001105966
LOEWENBAUM G WALTER II
12212 TECHNOLOGY BOULEVARD
AUSTIN
TX
78727
1
0
0
0
Common Stock
2020-08-04
4
S
0
50000
39.0206
D
450441
D
Common Stock
709415
I
Spouse
Common Stock
96614
I
Partnership
Common Stock
428520
I
Trusts
This sale is being made pursuant to a trading plan intended to comply with Rule 10b5-1, adopted by the seller on May 27,2020 for shares acquired as founder's stock prior to the IPO on March 30, 2000. The representation regarding the seller's knowledge of material adverse non-public information speaks as of the date that the aforementioned trading plan was adopted.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.95 to $39.19 inclusive. Mr. Loewenbaum undertakes to provide to Luminex Corporation, any security holder of Luminex Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
/S/ HARRISS T. CURRIE, AS ATTORNEY-IN-FACT FOR G. WALTER LOEWENBAUM II
2020-08-05